REG - Dr. Martens PLC - Appointment of joint corporate broker

Dr MartensAnnouncement

Today 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251010:nRSJ7965Ca&default-theme=true

RNS Number : 7965C  Dr. Martens PLC  10 October 2025

10 October 2025

Dr. Martens plc

Appointment of joint corporate broker

 

Dr. Martens plc announces the appointment of Berenberg as joint corporate
broker, to work alongside Investec and Goldman Sachs, with immediate effect.

 

Enquiries:

Dr. Martens:

Bethany Barnes, Director of Investor Relations & Corporate
Communications

+44 7825 187465

bethany.barnes@drmartens.com

 

Berenberg:

Ben Wright / Marie Moy

+44 (0) 203 207 7800

 

 

 

About Dr. Martens:

Dr. Martens is an iconic British footwear brand founded in Northamptonshire,
England. Its first silhouette, the 1460 boot - named after the date it was
produced - rolled off the production line on 1st April 1960. Originally chosen
by workers for their air-cushioned comfort and durability, "Docs" or "DM's"
were later adopted by musicians and subcultural pioneers who took them from
the street to the global stage.

Over six decades later, Dr. Martens operates in more than 60 countries and
employs around 3,700 people. The company continues to honour the brand's
heritage through its 'Made in England' footwear, manufactured at its original
Northamptonshire factory, while meeting global demand from multiple
high-quality production sites across Asia. All our products are made with an
unwavering commitment to craft, combined with innovative techniques.

Dr. Martens business spans Direct-to-Consumer (Retail and Ecommerce) and
Wholesale channels, with product segments including the brand's Original
silhouettes (the 1460 boot, 1461 shoe, 2976 Chelsea boot, and Adrian loafer),
Sandals, new product families such as Zebzag and Buzz, a Kids range, and an
expanding line of bags and accessories. Each collection embodies durability,
versatility, and individuality, while collaborations continue to push creative
boundaries and reach new wearers. Dr. Martens has transcended its roots while
staying true to its DNA - and the brand's trademark yellow welt stitching,
grooved sole edge, and scripted "With Bouncing Soles" heel loops are instantly
recognisable worldwide.

Dr. Martens plc (DOCS.L) is listed on the main market of the London Stock
Exchange and is a constituent of the FTSE 250 index.

For more information, visit www.drmartens.com or www.drmartensplc.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  APPPKCBKQBDDKKK